Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2021-12-01 00:00:00 ET · period of report 2021-11-30 · accession 0001808805-21-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-01 | 2021-11-30+ | NAUT | Posard Matthew L. | Dir | P - Purchase | $4.51 | +50.0K | 40.0K | New | +$225.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-30 | P | A | 20,000 | $4.57 | 20,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-01 | P | A | 10,000 | $4.50 | 30,000 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-01 | P | A | 10,000 | $4.45 | 50,000 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-01 | P | A | 10,000 | $4.46 | 40,000 | D | — | — |